2015 Aug 19:ajpregu.00239.2015. doi: 10.1152/ajpregu.00239.2015. [Epub ahead of print]
Abstract
The endocannabinoids are lipid-derived signaling molecules that control feeding and energy balance by activating CB1-type cannabinoid receptors in brain and peripheral tissues. Previous studies have shown that oral exposure to dietary fat stimulates endocannabinoid signaling in the rat small intestine, which provides positive feedback that drives further food intake and preference for fat-rich foods. We now describe an unexpectedly broader role for cholinergic signaling of the vagus nerve in the production of the endocannabinoid, 2-arachidonoyl-sn-glycerol (2-AG), in the small intestine. We show that food deprivation increases levels of 2-AG and its lipid precursor, 1,2-diacylglycerol, in rat jejunum mucosa in a time-dependent manner. This response is abrogated by surgical resection of the vagus nerve or pharmacological blockade of small intestinal subtype-3 muscarinic acetylcholine (m3 mAch) receptors, but not inhibition of subtype-1 muscarinic acetylcholine (m1 mAch). We further show that blockade of peripheral CB1 receptors or intestinal m3 mAch receptors inhibits refeeding in fasted rats. The results suggest that food deprivation stimulates 2-AG-dependent CB1 receptor activation through a mechanism that requires efferent vagal activation of m3 mAch receptors in the jejunum, which in turn, may promote feeding after a fast.
Copyright © 2015, American Journal of Physiology – Regulatory, Integrative and Comparative Physiology.
Copyright © 2015, American Journal of Physiology – Regulatory, Integrative and Comparative Physiology.
KEYWORDS:
cannabinoid receptor type 1 (CB1); cholinergic receptor; endocannabinoid; gut-brain; vagus nerve
- PMID:
- 26290104
- [PubMed – as supplied by publisher]